Skip to content
Tenderpoints
Tenderpoints™Hub

Episode Notes

Source / episode info

  • Episode: 360
  • Title: Divine Intervention Episode 360 – The Clutch Secondary Hypertension Podcast (Step 1-3)
  • Published: 2022-01-03
  • Source: Episode page

One-liner

This episode provides a comprehensive review of secondary causes of hypertension, integrating concepts from renal physiology (RAS workup), endocrinology (Conn syndrome, Cushing's), and genetics (MEN syndromes) to prepare students for complex board-style clinical vignettes.

High-yield summary

  • Renal Artery Stenosis (RAS): The hallmark is secondary hyperaldosteronism due to reduced renal perfusion activating the RAAS system; a key pitfall is avoiding ACE inhibitors/AR Bs in bilateral RAS.
  • Primary Hyperaldosteronism (Conn Syndrome): Characterized by resistant hypertension, hypokalemia, and metabolic alkalosis; diagnosis relies on an elevated Plasma Aldosterone to Plasma Renin Ratio (ARR) > 30 and failure of aldosterone suppression after saline infusion.
  • Cushing's Syndrome: Excess cortisol acts as a mineralocorticoid agonist, leading to sodium/water retention, potassium wasting, hypertension, hypokalemia, and metabolic alkalosis.
  • MEN2 Syndrome: The classic triad includes Medullary Thyroid Cancer (MTC), Pheochromocytoma, and Primary Hyperparathyroidism; the catecholamine excess from pheo is a major cause of HTN.
  • RAS Differential Diagnosis: Atherosclerosis affects the intima layer, while Fibromuscular Dysplasia (FMD) typically affects the media layer.
  • Acute Care/Trauma: Increased Intracranial Pressure (ICP) can trigger Cushing's Triad (Hypertension, Bradycardia, Irregular Respirations) due to CRH release.

Learning objectives

  • Differentiate the pathophysiology and diagnostic workup for primary vs. secondary hypertension.
  • Identify the specific anatomical differences between atherosclerotic RAS (intima) and fibromuscular dysplasia (media).
  • Recognize the classic clinical triad, associated hormones, and genetic basis of MEN2 syndrome.
  • Interpret laboratory findings (e.g., Aldosterone/Renin ratio, urinary electrolytes) to diagnose mineralocorticoid excess states.
  • Apply knowledge of endocrine axes (HPA axis, RAAS) in acute settings (e.g., increased ICP).

Board exam buzzwords

ConditionKey FindingAssociationBoard Exam Tip
Primary HyperaldosteronismHigh Aldosterone/Renin Ratio (>30)Resistant HTN, Hypokalemia, Metabolic AlkalosisAlways check the ARR first when evaluating resistant hypertension.
Cushing's SyndromeHypokalemic metabolic alkalosisCortisol acting on Mineralocorticoid Receptors (MR)Remember that cortisol excess mimics aldosterone effects.
MEN2 SyndromeMedullary Thyroid Cancer + PheochromocytomaRET proto-oncogene mutation; Catecholamine releaseMTC is the most common component found in this syndrome.
Licorice ingestionHTN, HypokalemiaInhibition of 11-hydroxylaseThis drug/substance mimics mineralocorticoid excess by increasing cortisol activity.

Rapid review table

TopicKey PointContextExam Relevance
Renal Artery StenosisRAAS activation (Ang II, Aldosterone )Reduced renal perfusion pressure due to RAS or Coarctation of the Aorta.High-yield for board questions; always consider it in HTN workup, especially with Doppler findings.
Conn SyndromePlasma Aldosterone/Plasma Renin Ratio (ARR) > 30Primary adrenal adenoma/hyperplasia causing autonomous aldosterone secretion.The diagnostic ratio is critical; the salt suppression test confirms autonomy.
Cushing's SyndromeCortisol excess -> MR activationHypercortisolism, regardless of source (e.g., licorice).Leads to hypokalemia and metabolic alkalosis due to mineralocorticoid effects.
MEN2 SyndromeMTC + Pheochromocytoma + PTH issuesRET gene mutation; Catecholamine excess from pheo.The triad is highly specific; HTN is driven by catecholamines, not just aldosterone.

Board-speak -> diagnosis

Board-speak / Vignette phraseDiagnosis / ConceptWhy it fits
Elderly patient with severe HTN and bilateral RAS who worsens significantly after starting an ACE inhibitor.Bilateral Renal Artery Stenosis (RAS)AC Ei/AR Bs reduce renal perfusion pressure, exacerbating the already compromised GFR in both kidneys.
Resistant hypertension, hypokalemia, metabolic alkalosis, and a high plasma aldosterone to renin ratio (>30).Primary Hyperaldosteronism (Conn Syndrome)This constellation points directly to autonomous mineralocorticoid excess, independent of RAAS feedback.
A patient with HTN, obesity, striae, proximal muscle weakness, and elevated cortisol levels.Cushing's Syndrome / Cortisol ExcessHigh cortisol acts on MR receptors, causing mineralocorticoid effects (HTN, hypokalemia).
Medullary thyroid cancer discovered in a patient who also has pheochromocytoma and hyperparathyroidism.Multiple Endocrine Neoplasia Type 2 (MEN2)This is the classic triad associated with RET proto-oncogene mutations; catecholamine excess causes HTN.
A child presenting with hypertension, requiring Doppler ultrasound of the renal arteries.Renovascular Hypertension / RASIn pediatrics, RAS must be ruled out early due to potential for rapid progression and specific management needs (e.g., coarctation).
Patient consuming excessive amounts of licorice candy develops HTN and hypokalemia.Licorice ingestion/Mineralocorticoid ExcessLicorice inhibits 11-hydroxylase, leading to cortisol accumulation and subsequent mineralocorticoid activity.

Differential diagnosis / distinguishing features

Primary Hyperaldosteronism vs. Secondary Causes of HTN

Key FeaturesDistinguishing FindingsNext Step
Primary (Conn): High Aldosterone/Renin Ratio (>30); Hypokalemia; Metabolic Alkalosis.Secondary: Low or normal ARR (e.g., RAS, Cushing's). The cause is external to the adrenal gland.Measure plasma aldosterone and renin levels before starting any anti-hypertensive agents.
Primary: Aldosterone secretion is autonomous/unregulated by RAAS feedback.Secondary: Renin production or volume status dictates aldosterone release (e.g., low renal perfusion -> high renin).If the ratio is normal but HTN persists, consider Cushing's syndrome workup.

Management pearls

  • Bilateral RAS Caution: Never initiate ACE inhibitors or AR Bs in patients with bilateral RAS due to the risk of precipitating acute kidney injury (AKI) by severely reducing already compromised renal perfusion pressure.
  • Conn Syndrome Workup: The initial screening test for resistant HTN is measuring the Plasma Aldosterone/Plasma Renin Ratio (ARR). A ratio > 30 strongly suggests primary hyperaldosteronism.
  • Diagnostic Confirmation: Confirm Conn syndrome with a salt suppression test (or saline infusion); failure of aldosterone levels to suppress confirms autonomy.
  • Adrenal Vein Sampling (AVS): This is the definitive diagnostic test for unilateral adrenal adenoma causing Conn syndrome, showing high aldosterone concentration in one vein and normal/suppressed levels in the other.

Don't miss

🚨
RAS Pitfall: In bilateral RAS, the risk of AKI from RAAS blockade outweighs the benefit; alternative agents (e.g., mineralocorticoid receptor antagonists like spironolactone) may be safer if appropriate.
🚨
MEN2 Triad: Always remember the triad: MTC + Pheochromocytoma + Hyperparathyroidism. The HTN is driven by catecholamines, not just volume expansion.
🚨
Cortisol Action: Cortisol excess (e.g., Cushing's, licorice) causes hypertension and hypokalemia because cortisol has sufficient affinity to activate the mineralocorticoid receptor (MR).
🚨
Pediatric RAS: Always perform a Doppler ultrasound of the renal arteries in children presenting with unexplained HTN.

Integration & clinical reasoning

  • Endocrine Integration: The adrenal gland is central; understanding how excess hormones (cortisol, aldosterone, catecholamines) mimic or disrupt normal feedback loops is key to diagnosing secondary hypertension.
  • Renal/Cardiovascular Integration: RAS and Coarctation of the Aorta are classic examples where vascular compromise leads to systemic HTN via RAAS activation.
  • Pharmacology Integration: The mechanism of action for mineralocorticoid receptor antagonists (e.g., Spironolactone, Eplerenone) directly targets the pathophysiology seen in Conn syndrome.

OMM / COMLEX integration

🦴
For COMLEX: know these viscerosomatics / Chapman points, but don't let OMM distract from emergent diagnosis and management.
  • Acute/Unstable Management: In any acute setting (e.g., septic shock, severe AKI), the priority is hemodynamic stabilization and addressing immediate life threats. The workup for secondary HTN should be deferred until the patient is stable.
  • Adrenal Crisis: While not directly discussed, remember that adrenal insufficiency (primary AI) requires immediate high-dose IV glucocorticoids (hydrocortisone) to prevent circulatory collapse due to mineralocorticoid deficiency.

Concept connections / cross-references

  • For detailed information on adrenal gland function and specific endocrine disorders: [Episode 37] (Hypothalamic/Pituitary Axis).
  • For comprehensive coverage of kidney physiology and tubular handling: [Episode 12] (Renal Tubular Function).
  • For understanding the general principles of hypertension management: [Episode 5] (General Cardiovascular Physiology).

High-yield association table

ConditionAssociationMechanismClinical Significance
Primary HyperaldosteronismHigh Aldosterone/Low Renin Ratio (>30)Autonomous aldosterone secretion -> Na+/H2 O retention, K+ wasting.Requires definitive diagnosis (AVS) to guide surgical vs. medical management.
Cushing's SyndromeMineralocorticoid Receptor AgonismHigh cortisol levels bind and activate MR, mimicking aldosterone effects.Causes hypokalemia and metabolic alkalosis; treatment often involves adrenalectomy or anti-mineralocorticoids.
MEN2 SyndromeMedullary Thyroid Cancer + PheochromocytomaRET proto-oncogene mutation -> Catecholamine overproduction.The HTN is due to massive alpha-1 agonist activity, requiring careful alpha-blockade pre-operatively.
Licorice IngestionInhibition of 11-hydroxylasePrevents the conversion of cortisol into inactive metabolites, leading to functional cortisol excess.A common and easily missed cause of mineralocorticoid excess in board questions.

Key terms glossary

TermDefinitionContextExample
Mineralocorticoid Receptor (MR)Receptor that binds mineralocorticoids (aldosterone, cortisol) leading to Na+ reabsorption and K+/H+ excretion.HTN/Electrolyte imbalance; Cushing's syndrome.Spironolactone is an MR antagonist used to treat Conn Syndrome.
Plasma Aldosterone/Renin Ratio (ARR)The ratio of circulating aldosterone levels to plasma renin activity.Screening for primary hyperaldosteronism.A ratio > 30 strongly suggests autonomous aldosterone secretion.
11-hydroxylaseEnzyme responsible for converting cortisol into inactive metabolites.Drug/Substance toxicity; Cushing's workup.Licorice is a potent inhibitor of this enzyme, causing functional hypercortisolism.
Fibromuscular Dysplasia (FMD)Non-atherosclerotic, non-inflammatory vasculopathy affecting medium-sized arteries.Differential diagnosis for RAS in younger patients.Affects the media layer of the artery wall, unlike atherosclerosis which affects the intima.

Study optimization

TopicStudy ApproachPriorityResources
Secondary HTN SyndromesCreate flowcharts linking clinical signs (e.g., hypokalemia) to underlying pathophysiology (MR agonism).HighReview board vignettes focusing on the mechanism of electrolyte disturbance.
RAS WorkupMaster the differential diagnosis between atherosclerotic and non-atherosclerotic causes, paying attention to vessel layers affected.Medium-HighPractice interpreting Doppler ultrasound findings in pediatric HTN.
Endocrine EmergenciesMemorize the key diagnostic ratios (ARR > 30) and classic triads (MEN2).HighUse flashcards for "Clinical Presentation -> Diagnosis."

Question pattern recognition

  • Pattern: Resistant Hypertension + Hypokalemia/Metabolic Alkalosis -> Primary Hyperaldosteronism. Always check the ARR. If high, confirm with salt suppression test and consider AVS.
  • Pattern: HTN in a child -> Doppler Ultrasound of Renal Arteries. Never assume RAS is not present; it must be ruled out early.
  • Pattern: Triad of MTC + Pheochromocytoma + Hyperparathyroidism -> MEN2 Syndrome. The catecholamine excess from pheo drives the HTN, making alpha-blockade paramount for pre-op management.

Test yourself

Common mistakes to avoid

🚫
Mistake 1: Confusing RAS layers. Do not confuse atherosclerotic RAS (intima) with FMD (media). The layer affected dictates the underlying pathology.
🚫
Mistake 2: Over-reliance on algorithms for Conn Syndrome. While ARR > 30 is a strong indicator, always remember that clinical context and differential diagnoses (e.g., Cushing's) must be considered before diagnosis.
🚫
Mistake 3: Assuming all HTN causes are volume expansion related. Some causes (like MEN2/Pheo) cause HTN primarily through massive vasoconstriction from catecholamines, not just increased blood volume.

Common traps

⚠️
Trap 1: The AC Ei/ARB trap in RAS. Students often forget that RAAS blockade is dangerous when the kidney is already compromised by bilateral stenosis.
⚠️
Trap 2: Confusing Cushing's and Conn Syndrome. Both cause hypokalemia/metabolic alkalosis, but Cushing's involves cortisol excess (often exogenous or adrenal tumor), while Conn syndrome involves aldosterone excess (adrenal adenoma). The underlying mechanism is MR agonism in both.
⚠️
Trap 3: Assuming the diagnosis of HTN. Never assume that hypertension means volume overload; it could be pure vasoconstriction (e.g., pheochromocytoma) or mineralocorticoid effect.